Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CDK4/6 inhibitors in HER2-positive breast cancer.
Corona SP, Ravelli A, Cretella D, Cappelletti MR, Zanotti L, Dester M, Gobbi A, Petronini PG, Generali D. Corona SP, et al. Among authors: generali d. Crit Rev Oncol Hematol. 2017 Apr;112:208-214. doi: 10.1016/j.critrevonc.2017.02.022. Epub 2017 Feb 24. Crit Rev Oncol Hematol. 2017. PMID: 28325261 Review.
Isolated Testicular Metastasis from Prostate Cancer.
Bonetta A, Generali D, Corona SP, Cancarini G, Brenna SG, Pacifico C, Roviello G. Bonetta A, et al. Among authors: generali d. Am J Case Rep. 2017 Aug 14;18:887-889. doi: 10.12659/ajcr.904521. Am J Case Rep. 2017. PMID: 28804118 Free PMC article.
Bevacizumab in small cell lung cancer.
Roviello G, Sobhani N, Generali D. Roviello G, et al. Among authors: generali d. Ann Transl Med. 2017 Sep;5(17):361. doi: 10.21037/atm.2017.06.44. Ann Transl Med. 2017. PMID: 28936455 Free PMC article. No abstract available.
Advances in systemic therapy for malignant mesothelioma: future perspectives.
Sobhani N, Corona SP, Bonazza D, Ianza A, Pivetta T, Roviello G, Cortale M, Guglielmi A, Zanconati F, Generali D. Sobhani N, et al. Among authors: generali d. Future Oncol. 2017 Oct;13(23):2083-2101. doi: 10.2217/fon-2017-0224. Epub 2017 Oct 6. Future Oncol. 2017. PMID: 28984470 Review.
Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer.
Milani M, Venturini S, Bonardi S, Allevi G, Strina C, Cappelletti MR, Corona SP, Aguggini S, Bottini A, Berruti A, Jubb A, Campo L, Harris AL, Gatter K, Fox SB, Generali D, Roviello G. Milani M, et al. Among authors: generali d. Oncotarget. 2017 Aug 14;8(45):78870-78881. doi: 10.18632/oncotarget.20239. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108271 Free PMC article.
322 results